Literature DB >> 10047656

Comparison of longevity, pacing, and sensing characteristics of steroid-eluting epicardial versus conventional endocardial pacing leads in children.

G C Beaufort-Krol1, H Mulder, D Nagelkerke, T W Waterbolk, M T Bink-Boelkens.   

Abstract

OBJECTIVE: Because of either cardiac anatomy or small size, pacing in children often occurs by means of epicardial leads. The disadvantage of epicardial leads is the shorter longevity of these leads compared with endocardial leads. During short-term follow-up, improved stimulation thresholds were found for the newer steroid-eluting epicardial leads. The longevity of these leads may be better than that of conventional epicardial leads. An improved longevity of epicardial leads may influence the choice to either epicardial or endocardial pacing in children.
METHODS: We studied the longevity and the pacing and sensing characteristics of 33 steroid-eluting epicardial pacing leads (group I, 15 atrial, 18 ventricular) implanted between November 1991 and October 1996 in 20 children with a mean age of 7.6 +/- 6.5 years (mean +/- SD), and 29 endocardial pacing leads (group II, 15 atrial, 14 ventricular) implanted during the same period in 21 children with a mean age of 11.7 +/- 4.7 years.
RESULTS: The mean follow-up in group I was 2.9 +/- 1.6 years and in group II 3.1 +/- 1.7 years (P =.61). The 2-year survival of the leads in group I was 91% +/- 5% and in group II 86% +/- 7% (P =.97). Lead failure occurred in both groups in 4 leads (P =.85). Chronic stimulation and sensing thresholds were similar.
CONCLUSIONS: Steroid-eluting epicardial leads have the same longevity as the conventional endocardial leads. Pacing and sensing thresholds were similar and did not change during follow-up. Therefore steroid-eluting epicardial pacing leads are a good alternative for endocardial leads in small children and in children with congenital heart disease.

Entities:  

Mesh:

Year:  1999        PMID: 10047656     DOI: 10.1016/s0022-5223(99)70332-6

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  Special problems of pacing in children.

Authors:  Herwig Antretter; Joshua Colvin; Ulli Schweigmann; Herbert Hangler; Daniel Hofer; Karin Dunst; Josef Margreiter; Guenther Laufer
Journal:  Indian Pacing Electrophysiol J       Date:  2003-01-01

2.  An alternate technique to pacing in complex congenital heart disease: assessment of the left thoracotomy approach.

Authors:  Ashley D Roberts; Suvro Sett; Jacques Leblanc; Shubhayan Sanatani
Journal:  Can J Cardiol       Date:  2006-05-01       Impact factor: 5.223

3.  Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict.

Authors:  M C Post; W Budts; A Van de Bruaene; R Willems; B Meyns; F Rega; M Gewillig
Journal:  Neth Heart J       Date:  2011-08       Impact factor: 2.380

Review 4.  Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Authors:  Scott Anjewierden; Peter F Aziz
Journal:  Curr Cardiol Rep       Date:  2018-07-18       Impact factor: 2.931

5.  Epicardial versus endocardial permanent pacing in adults with congenital heart disease.

Authors:  Christopher John McLeod; Christine H Attenhofer Jost; Carole A Warnes; David Hodge; Linda Hyberger; Heidi M Connolly; Samuel J Asirvatham; Joseph A Dearani; David L Hayes; Naser M Ammash
Journal:  J Interv Card Electrophysiol       Date:  2010-06-19       Impact factor: 1.900

6.  Fractally coated myocardial pacemaker leads in children.

Authors:  Thomas Borth-Bruhns; Matthias Gass
Journal:  J Interv Card Electrophysiol       Date:  2005-10       Impact factor: 1.900

7.  Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients.

Authors:  Elizabeth B Fortescue; Charles I Berul; Frank Cecchin; Edward P Walsh; John K Triedman; Mark E Alexander
Journal:  J Interv Card Electrophysiol       Date:  2005-10       Impact factor: 1.900

8.  Endocardial and epicardial steroid lead pacing in the neonatal and paediatric age group.

Authors:  F Udink ten Cate; J Breur; N Boramanand; J Crosson; A Friedman; J Brenner; E Meijboom; N Sreeram
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 9.  Pacing device therapy in infants and children: a review.

Authors:  Daiji Takeuchi; Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-10-27       Impact factor: 1.731

10.  Permanent atrial pacing lead implant route after Fontan operation.

Authors:  Kazuhiro Takahashi; Frank Cecchin; Elizabeth Fortescue; Charles I Berul; Mark E Alexander; Edward P Walsh; Francis Fynn-Thompson; John K Triedman
Journal:  Pacing Clin Electrophysiol       Date:  2009-06       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.